UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 Current Report


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of report (date of earliest event reported): February 24, 2009

                               Balchem Corporation
             (Exact name of registrant as specified in its charter)

Maryland                                  1-13648            13-2578432
(State or other jurisdiction of   (Commission File Number)   (IRS Employer
incorporation)                                               Identification No.)

                       P.O. Box 600, New Hampton, NY 10958
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (845) 326-5600

      Check the  appropriate  box below if the Form 8-K  filing is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))




Item 2.02 Results of Operations and Financial Condition

On February  24, 2009,  Balchem  Corporation,  reported  earnings for its fourth
quarter ended  December 31, 2008.  The full text of the press release  issued in
connection with the announcement is attached as Exhibit 99.1.

The  information in this Form 8-K  (including  Exhibit 99.1) shall not be deemed
"filed" for purposes of Section 18 of the  Securities  Exchange Act of 1934 (the
"Exchange  Act") or otherwise  subject to the  liabilities of that section,  nor
shall it be deemed  incorporated by reference in any filing under the Securities
Act of 1933 or the  Exchange  Act,  except as  expressly  set forth by  specific
reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits.

99.1 Press Release of Balchem Corporation dated February 24, 2009, reporting its
financial results for the fourth quarter of 2008.







                                    SIGNATURE

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                                BALCHEM CORPORATION


                                                By:/s/ Francis J. Fitzpatrick
                                                --------------------------------
                                                Francis J. Fitzpatrick
                                                Chief Financial Officer

Dated: March 9, 2009





                                  Exhibit Index


Exhibit Number                     Description
--------------                     -----------


99.1              Press Release of Balchem Corporation, dated February 24, 2009